These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 3718564

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP, Ruddy S, Schwartz LB, Moxley G.
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [Abstract] [Full Text] [Related]

  • 4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH, Nydegger UE, Perrin LH, McCormic J, Fehr K, Miescher PA.
    Rheumatology; 1975 Dec; 6():52-9. PubMed ID: 1202608
    [Abstract] [Full Text] [Related]

  • 5. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.
    Doherty M, Richards N, Hornby J, Powell R.
    Ann Rheum Dis; 1988 Mar; 47(3):190-7. PubMed ID: 2833185
    [Abstract] [Full Text] [Related]

  • 6. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I, Nikolov K, Petrova P.
    Vutr Boles; 1987 Mar; 26(4):66-70. PubMed ID: 3499707
    [Abstract] [Full Text] [Related]

  • 7. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
    Ruddy S, Fearon DT, Austen KF.
    Arthritis Rheum; 1975 Mar; 18(4):289-95. PubMed ID: 808229
    [Abstract] [Full Text] [Related]

  • 8. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
    Mellbye OJ, Naes B, Munthe E.
    Ann Rheum Dis; 1976 Jun; 35(3):233-9. PubMed ID: 825053
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the complement split product C3dg in synovial fluid as a possible diagnostic guide in inflammatory arthropathies.
    Michel BA, Schlumpf U, Simmler F.
    J Rheumatol; 1989 Sep; 16(9):1201-4. PubMed ID: 2810276
    [Abstract] [Full Text] [Related]

  • 10. [Complement in rheumatoid articular inflammation].
    Boloşiu HD, Duţu A, Duţu D, Duma V, Gligore V.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975 Sep; 27(6):469-74. PubMed ID: 3842
    [No Abstract] [Full Text] [Related]

  • 11. [Complement in the synovial fluid. Diagnostic usefulness of its correction with protein fractions].
    Gambari PF, Volante D, Stone GC, Ostuni PA, Ruffatti A, Punzi L, Todesco S.
    Recenti Prog Med; 1981 Jul; 71(1):69-75. PubMed ID: 7313285
    [No Abstract] [Full Text] [Related]

  • 12. [The C'-3 constituent of the complement and rheumatoid factors in serum-synovial fluid paris in progressive polyarthritis and reactive synovites due to local causes (author's transl)].
    Hrncír Z, Tichý M, Salavec M, Vavrina J.
    Cas Lek Cesk; 1976 Dec 03; 115(48):1487-90. PubMed ID: 1000565
    [No Abstract] [Full Text] [Related]

  • 13. Measurement of terminal complement complexes in rheumatoid arthritis.
    Morgan BP, Daniels RH, Williams BD.
    Clin Exp Immunol; 1988 Sep 03; 73(3):473-8. PubMed ID: 3208454
    [Abstract] [Full Text] [Related]

  • 14. [Blood and synovial levels of C 3-activator (beta-2-glycoprotein II) in rheumatoid arthritis].
    Ambanelli U, Troise W, Riccardi L.
    Reumatismo; 1975 Sep 03; 27(1):37-44. PubMed ID: 1233648
    [No Abstract] [Full Text] [Related]

  • 15. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B.
    Z Rheumatol; 1981 Sep 03; 40(5):208-12. PubMed ID: 6914866
    [Abstract] [Full Text] [Related]

  • 16. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG, Berglund K, Johnson U, Laurell AB, Sturfelt G.
    Int Arch Allergy Appl Immunol; 1986 Sep 03; 79(2):113-9. PubMed ID: 3484727
    [Abstract] [Full Text] [Related]

  • 17. [Humoral immunity in rheumatoid arthritis].
    Xu WD.
    Zhonghua Yi Xue Za Zhi; 1985 Sep 03; 65(9):517-20. PubMed ID: 3935285
    [No Abstract] [Full Text] [Related]

  • 18. [C4 component of complement, rheumatoid factors and circulating immunocomplexes in rheumatoid-arthritis and reactive synovitides of local origin; serum synovial fluid].
    Hrncír Z, Tichý M, Salavec M, Vavrina J.
    Cas Lek Cesk; 1978 Dec 08; 117(49):1526-9. PubMed ID: 737699
    [No Abstract] [Full Text] [Related]

  • 19. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis.
    Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E.
    Scand J Rheumatol; 1991 Dec 08; 20(3):183-9. PubMed ID: 2068540
    [Abstract] [Full Text] [Related]

  • 20. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E, Nieuwland R, Tak PP, Pronk LM, Schaap MC, Sturk A, Hack CE.
    Ann Rheum Dis; 2007 Aug 08; 66(8):1085-92. PubMed ID: 17261534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.